
Active Research Studies
Current NIDA CTN studies led by NY Node Investigators
NY Node Administration
Contact: Ryan McDonald, Node Coordinator
Phone: 646-754-4795
Email: Ryan.Mcdonald@NYULangone.org
Low-threshold Buprenorphine Treatment at Syringe Services Programs: A Type I Hybrid Effectiveness-implementation Trial (CTN-0155)
More about CTN-0155 study
NYN Investigators: Aaron Fox, Aimee Campbell
Contact: ADFOX@montefiore.org
Better Together: Integrating MOUD in African American Community Settings (CTN-0144)
More about CTN-0144
NYN Investigator: Ayana Jordan
Contact: Ayana.Jordan@NYULangone.org
Collaborative Care for Polysubstance use in Primary Care Settings (Co-Care; CTN-0139)
More about CTN-0139
NYN Investigator: Jennifer McNeely
Contact: Jennifer.Mcneely@NYULangone.org
Office-Based Methadone versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment – A Randomized Pragmatic Hybrid Effectiveness/Implementation Trial (CTN-0131)
More about CTN-0131
NYN Investigator: Ayana Jordan
Contact: Ayana.Jordan@NYULangone.org
Longitudinal Follow-up of Individuals with Opioid Use Disorder (CTN-0126)
More about CTN-0126
NYN Investigator: Matisyahu Shulman
Contact: Matisyahu.Shulman@nyspi.columbia.edu
Optimal Policies to Improve Methadone Maintenance Adherence Long-Term (OPTIMMAL; CTN-0112)
More about CTN-0112
NYN Investigators: A. Robin Williams, Noa Krawczyk
Contact: aw2879@columbia.edu
Subthreshold Opioid Use Disorder Prevention (STOP) Trial (CTN-0101)
More about CTN-0101
NYN Investigator: Jennifer McNeely
Contact: Jennifer.Mcneely@NYULangone.org
Optimizing Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (CTN-0100)
More about CTN-0100
NYN Investigator(s): Edward Nunes, John Rotrosen
Contact: edward.nunes@nyspi.columbia.edu
Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder (CTN-0097)
More about CTN-0097
NYN Investigator: Adam Bisaga
Contact: adam.bisaga@nyspi.columbia.edu
Culturally Centering Delivery of Medications for OUD with American Indian/Alaska Native Communities (CTN-0096)
More about CTN-0096
NYN Investigator: Aimee Campbell
Contact: anc2002@cumc.columbia.edu
Ancillary Study of the Adoption and Sustainability of ED-Initiated Buprenorphine (CTN-0079-A1)
More about CTN-0079-A1
NYN Investigator: Ryan McCormack
Contact: Ryan.McCormack@NYULangone.org
Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT; CTN-0079)
More about CTN-0079
NYN Investigator: Ryan McCormack
Contact: Ryan.McCormack@NYULangone.org